ELUCIDATION OF SIGNIFICANCE OF c-met EXPRESSION IN ACTIVATED HEPATIC STELLATE GELLS AND ITS APPLICATION OF THERAPEUTIC STRATEGY
ELUCIDATION OF SIGNIFICANCE OF c-met EXPRESSION IN ACTIVATED HEPATIC STELLATE GELLS AND ITS APPLICATION OF THERAPEUTIC STRATEGY
批准号:
09670517
负责人:
IKEDA Hitoshi
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
(1)我们发现活化的大鼠肝星状细胞表达肝细胞生长因子(HGF)受体c-met。在培养激活的星状细胞中,通过Northern和Western提示分析测定c-met的表达。HGF与活化的星状细胞特异性结合,Scatchard分析显示表观K_d为1.5 nM。此外,在四氯化碳处理8周的大鼠星状细胞中检测c-met mRNA的表达。(2)在培养激活的星状细胞中,HGF增加了c-met mRNA的表达。HGF增强了细胞的DNA合成和转化生长因子β 1 (tgfβ 1)的产生,而HGF不影响胶原合成和平滑肌α -肌动蛋白的表达。(3)鉴于HGF是由星状细胞产生的,HGF可能通过自分泌机制影响星状细胞。由于星状细胞的增殖是肝纤维化的主要特征之一,TGFbeta1被认为是一种纤维化细胞因子,我们的研究结果表明HGF可能加速肝纤维化的发生。然而,最近的证据显示,在四氯化碳或二甲基亚硝胺处理的大鼠中,HGF消除了肝纤维化。我们推测,HGF对肝纤维化的抑制作用可能不是由于对星状细胞的直接作用,而是通过HGF可能的细胞保护作用间接作用。
英文摘要
(1) We have found that activated rat hepatic stellate cells express c-met, the receptor of hepatocyte growth factor (HGF). In culture-activated stellate cells, c-met expression was determined by Northern and Western hint analyses. Specific binding of HGF to activated stellate cells was determined, and Scatchard analysis indicated an apparent K_d of 1.5 nM.Moreover, c-met mRNA expression was detected in stellate cells isolated from rats treated with carbon tetrachloride for 8 weeks.(2) In culture-activated stellate cells, HGF increased c-met mRNA level. HGF enhanced DNA synthesis and transforming growth factor beta1 (TGFbeta1) production by the cells, whereas HGF did not affect collagen synthesis nor smooth muscle alpha-actin expression.(3) Considering that HGF is produced by stellate cells, HGF may affect those cells by autocrine mechanism. Because the proliferation of stellate cells is one of the main features of hepatic fibrosis and TGFbeta1 is known as a fibrogenic cytokine, our results suggest that HGF might accelerate hepatic fibrogenesis. However, recent evidence has revealed that HGF abrogates hepatic fibrosis in rats treated with carbon tetrachloride or dimethylnitrosamine. We speculate that this inhibitory effect of HGF on hepatic fibrosis may not be due to the direct action on stellate cells, but to the indirect action through, say possible cytoprotective effect of HGF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel treatment for liver injury by modulation oflipid mediator effects
-
批准号:22590716
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2010
-
负责人:IKEDA Hitoshi
-
依托单位:
Elucidation of a role of sphingosine 1-phosphate on liver damage
-
批准号:19590750
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:IKEDA Hitoshi
-
依托单位:
Elucidation of the clinical significance of autotaxin and lysophosphatidic acid in liver diseases.
-
批准号:17590618
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:IKEDA Hitoshi
-
依托单位:
Mechanisms of Hepatoblastoma Carcinogenesis in Low Birth Weight Infants
-
批准号:15591892
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2003
-
负责人:IKEDA Hitoshi
-
依托单位:
Elucidation of the mechanism of the inhibitory effect of sphingosine 1-phosphate on hepatocyte proliferation and the significance in liver regeneration
-
批准号:14570451
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2002
-
负责人:IKEDA Hitoshi
-
依托单位:
-General Study of the Chinese Agriculture and Rural Economy after joining World Trade Organization-
-
批准号:14402031
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.62万
-
财政年份:2002
-
负责人:IKEDA Hitoshi
-
依托单位:
PORTAL HYPERTENSION-ELUCIDATION OF THE MECHANISM IN THE LIGHT OF FUNCTIONAL ABNORMALITIES OF HEPATIC STELLATE CELLS AND DEVELOPMENT OF THERAPEUTIC STRATEGY
-
批准号:12670461
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:IKEDA Hitoshi
-
依托单位:
Pathogenetic roles of human endogenous retroviruses in autoimmune diseases
-
批准号:12670193
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2000
-
负责人:IKEDA Hitoshi
-
依托单位:
Mapping of the gene for Holmes' ataxia by searching of triplet repeats
-
批准号:09470057
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.65万
-
财政年份:1997
-
负责人:IKEDA Hitoshi
-
依托单位:
Platelet Epidermal Growth Factor and Liver Regeneration
-
批准号:62570313
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1987
-
负责人:IKEDA Hitoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
复方香巴戟膏介导的NO/HGF/c-met通路活化卫星细胞促进损伤后肌肉组织再生
-
批准号:2025JJ70694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:丁轩
-
依托单位:
安罗替尼通过调控HGF/c-MET信号通路与自噬相互作用促进人脑胶质瘤细胞凋亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘细帮
-
依托单位:
HGF/c-Met信号通路对脑梗死中血脑屏障的保护作用及机制的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘晖
-
依托单位:
电针联合骨髓间充质干细胞移植通过HGF/c-Met/mTOR信号通路抑制肛门括约肌卫星细胞自噬的机制研究
-
批准号:82305230
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李鹏
-
依托单位:
HGF/c-Met/STAT3信号对GMSC调控树突状细胞改善过敏性哮喘的作用研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:方倩楠
-
依托单位:
薯蓣皂苷元通过调节Daxx乙酰化抑制HGF/c-Met通路抗乳腺癌机制的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王佳
-
依托单位:
金荞麦黄酮类化合物协同靶向 HGF/c-MET 信号通路抑制NSCLC 侵袭转移的机制研究
-
批准号:2022JJ40530
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:李弘德
-
依托单位:
HGF/c-Met靶向E2F1形成正反馈环路促进胰腺癌神经浸润的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:秦涛
-
依托单位:
硫酸乙酰肝素差向异构化修饰对非小细胞肺癌中HGF/c-Met信号通路的调控作用与机制研究
-
批准号:32160222
-
项目类别:地区科学基金项目
-
资助金额:36万元
-
批准年份:2021
-
负责人:崔浩
-
依托单位:
基于HGF/c-Met信号通路探讨清解益肺苗方抑制NSCLC增殖及对EGFR-TKI获得性耐药的机制研究
-
批准号:82160952
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2021
-
负责人:刘炜
-
依托单位: